Trade BLCO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bausch + Lomb Corporation (BLCO) is trading at US$16.80, down 0.30% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$6.16B. Over the past 52 weeks, BLCO has traded between US$13.77 and US$18.92. On Syfe you can trade BLCO with $0 commission and add it to your watchlist.
| Previous close | US$16.85 |
|---|---|
| Market cap | US$6.16B |
| P/E ratio | 16.55 |
| 52-week range | US$13.77 – US$18.92 |
| Volume | 474.88K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bausch + Lomb Corporation
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Year: 2022
UBS Adjusts Price Target on Bausch + Lomb to $23 From $21, Maintains Buy Rating
Jul 30, 1:07 PM · MT Newswires
Bausch + Lomb Q2 Adjusted Earnings, Revenue Rise; Full-Year Revenue Outlook Raised
Jul 29, 12:06 PM · MT Newswires
Bausch + Lomb Corporation (BLCO) stock is trading at US$16.80, -0.30% from the previous close of US$16.85.
The market cap for Bausch + Lomb Corporation (BLCO) stock is approximately US$6.16B.
The price-to-earnings ratio for Bausch + Lomb Corporation (BLCO) is 16.55, based on the latest reported earnings.
The 52-week high for Bausch + Lomb Corporation (BLCO) stock is US$18.92.
The 52-week low for Bausch + Lomb Corporation (BLCO) stock is US$13.77.
Bausch + Lomb Corporation (BLCO) does not currently pay a dividend.
Stay on top of BLCO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
